China Resources Pharmaceutical Group Limited Stock
Stocks
3320
HK0000311099
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Hong Kong S.E.
04:08:14 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 4.295 HKD | -0.81% |
|
-1.26% | -3.48% |
| 09-01 | China Resources Pharma Unit's Bond Program Registration Accepted in China | MT |
| 08-24 | China Resources Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 26.98B 3.44B 3.02B 2.85B 2.6B 4.86B 330B 4.9B 34.12B 13.21B 168B 12.92B 12.64B 541B | P/E 2026 * |
5.51x | P/E 2027 * | 5.17x |
|---|---|---|---|---|---|
| Enterprise Value | 76.22B 9.72B 8.53B 8.05B 7.34B 13.74B 931B 13.84B 96.36B 37.32B 476B 36.48B 35.69B 1,529B | EV / Sales 2026 * |
0.23x | EV / Sales 2027 * | 0.2x |
| Free-Float |
29.17% | Yield 2026 * |
4.74% | Yield 2027 * | 5.13% |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 3320 | Delayed | |
Tradegate
| 640 | Real-time | |
|
Deutsche Boerse AG
| 640 | Delayed | |
|
Börse Stuttgart
| 640 | Delayed | |
|
Boerse Muenchen
| 640 | Real-time |
| 1 day | -0.81% | ||
| 1 week | -1.26% | ||
| Current month | -3.91% | ||
| 1 month | -6.32% | ||
| 3 months | -0.35% | ||
| 6 months | -19.42% | ||
| Current year | -3.48% |
| 1 week | 4.23 |  | 4.4 |
| 1 month | 4.23 | | 4.64 |
| Current year | 4.22 | | 6.53 |
| 1 year | 4.22 | | 6.53 |
| 3 years | 4.22 | | 7.11 |
| 5 years | 3.18 | | 8.13 |
| 10 years | 3.18 | | 13.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jie Cheng
PSD | President | 47 | 2025-08-25 |
Rong Hui Deng
DFI | Director of Finance/CFO | 54 | 2023-06-12 |
Wing Yi Wan
SEC | Corporate Secretary | - | 2025-12-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Ting Mei Fu
BRD | Director/Board Member | 59 | 2016-05-31 |
Ke Jian Zhang
BRD | Director/Board Member | 70 | 2016-06-19 |
Xiao Song Bai
CHM | Chairman | 55 | 2024-08-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/1/20 | Other | Chief Executive Officer | 200,000 | 0.0032% | ||
| 3/31/20 | Other | Chief Executive Officer | 100,000 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.81% | -1.26% | -9.20% | -17.08% | 3.44B | |
| +0.13% | +2.65% | +63.34% | +115.17% | 1,055B | |
| +0.20% | +0.46% | +50.92% | +70.56% | 654B | |
| -0.29% | +0.14% | +19.82% | +71.75% | 467B | |
| -0.85% | +0.98% | +42.13% | +44.64% | 348B | |
| +0.71% | +4.08% | +21.75% | +28.83% | 275B | |
| +1.23% | +0.42% | +14.11% | +12.43% | 258B | |
| +2.11% | +7.51% | +51.88% | +54.11% | 224B | |
| +0.83% | +0.55% | +34.64% | +99.83% | 187B | |
| 0.00% | -10.14% | -27.40% | -61.08% | 171B | |
| Average | +0.33% | +0.54% | +26.20% | +41.91% | 364.18B | |
| Weighted average by Cap. | +0.27% | +1.31% | +40.38% | +68.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 328B 41.78B 36.67B 34.63B 31.56B 59.08B 4,005B 59.5B 414B 161B 2,046B 157B 153B 6,576B | 340B 43.38B 38.07B 35.95B 32.76B 61.33B 4,158B 61.77B 430B 167B 2,124B 163B 159B 6,827B |
| Net income | 4.82B 614M 539M 509M 464M 868M 58.86B 874M 6.09B 2.36B 30.07B 2.31B 2.26B 96.64B | 5.17B 659M 578M 546M 498M 932M 63.18B 939M 6.54B 2.53B 32.28B 2.47B 2.42B 104B |
| Net Debt | 49.24B 6.28B 5.51B 5.2B 4.74B 8.87B 602B 8.94B 62.25B 24.11B 307B 23.57B 23.06B 988B | 42.53B 5.42B 4.76B 4.49B 4.09B 7.67B 520B 7.72B 53.77B 20.83B 265B 20.36B 19.92B 853B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-25 | HK$4.295 | -0.81% | 1,517,646 |
| 26-09-24 | HK$4.330 | -0.80% | 5,820,000 |
| 26-09-23 | HK$4.365 | +0.92% | 4,406,750 |
| 26-09-22 | HK$4.325 | -1.26% | 4,252,000 |
| 26-09-21 | HK$4.380 | +0.69% | 11,264,687 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 3320 Stock
Select your edition
All financial news and data tailored to specific country editions
